Skip to content

Clinical trial of interventional diagnosis and treatment operation navigation system and disposable coaxial navigation needle

Clinical trial of interventional diagnosis and treatment operation navigation system and disposable coaxial navigation needle

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043361
Enrollment
Unknown
Registered
2021-02-11
Start date
2019-07-26
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Space-occupying lesions in the chest and abdomen

Interventions

1:Interventional diagnosis and treatment operation navigation system and disposable coaxial navigation needle
2:Coaxial guided biopsy needle

Sponsors

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old (including 18 and 65 years old), regardless of gender; 2. Clinical and imaging diagnosis is a space-occupying lesion of the chest or abdomen, and a needle biopsy is required; 3. The diameter of the lesion <= 50mm; 4. Can cooperate with this study; 5. Volunteer to participate in this clinical trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who need more than 1 biopsy; 2. Uncorrectable coagulation dysfunction, or bleeding; 3. Severe cardiopulmonary insufficiency (such as severe pulmonary hypertension); 4. Severe hepatic and renal insufficiency (alanine aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 times the upper limit of normal, alkaline phosphatase (ALP) > 5 times the upper limit of normal, total bilirubin (TBil) > 3 times the upper limit of normal, serum creatinine (Scr) > 178 µmol/L), combined with other clinical manifestations, comprehensively determined by the investigator; 5. Obvious infectious lesions on the puncture path; 6. Pregnant or lactating women; 7. Using devices that are subject to electromagnetic interference (such as pacemakers) or implants that can interfere with electromagnetics; 8. Patients who have other counter-indications for CT-guided needle biopsy treatment or other reasons unsuitable for enrolment.

Design outcomes

Primary

MeasureTime frame
The positioning success rate with the number of puncture adjustments not greater than 2;Adverse events;Performance;

Secondary

MeasureTime frame
The positioning success rate, positioning accuracy, and the total number of CT scans when the number of puncture adjustments is not greater than one;

Countries

China

Contacts

Public ContactXiaoyi Ding

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

dxy10456@rjh.com.cn+86 18917762068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026